Mainland China

9th Technical Conference of CSCEC Middle East: Redefining Modern Construction with Revolutionary Methods

DUBAI, UAE, Dec. 11, 2025 /PRNewswire/ -- In late October, the 9th Technical Conference, hosted by CSCEC Middle East and co-organized by the Society of Engineers-UAE, was successfully held. Under the theme "Showcasing Revolutionary Modern Methods of Construction to Redefine Tomorrow", this year's...

2025-12-11 16:36 1070

Youdao 2025 Annual General Meeting of Shareholders

BEIJING, Dec. 11, 2025 /PRNewswire/ -- As announced on November 20, 2025, the Company is going to hold its annual general meeting of shareholders ("AGM") at itsBeijing offices on December 16, 2025 at 3:00 p.m. – 5:00 p.m. (Beijing Time). To watch the live broadcasting of the AGM, please click the...

2025-12-11 16:30 866

Nexteer Builds on Growth Momentum at 2025 Global Strategy Summit in Suzhou, China

SUZHOU, China, Dec. 11, 2025 /PRNewswire/ -- Nexteer Automotive, a global leader in intuitive motion control, held its annual Global Strategy Summit in Suzhou,China. The Summit's first-ever presence in China highlights Nexteer's strategic focus on leveraging its success inChina's fast-moving mark...

2025-12-11 15:56 1481

Yiren Digital Wins "Technology Innovation Leadership Award for Listed Companies" at the 23rd China's Financial Annual Champion Awards

BEIJING, Dec. 11, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leadingFintech company specializing in digital consumer lending, insurance and financial technology innovation acrossChina and Southeast Asia, today announced it has been awarded the "Techn...

2025-12-11 15:40 2507

9th Technical Conference of CSCEC Middle East: Redefining Modern Construction with Revolutionary Methods

DUBAI, UAE, Dec. 11, 2025 /PRNewswire/ -- In late October, the 9th Technical Conference, hosted by CSCEC Middle East and co-organized by the Society of Engineers-UAE, was successfully held. Under the theme "Showcasing Revolutionary Modern Methods of Construction to Redefine Tomorrow", this year's...

2025-12-11 14:44 1178

Yuans Technology: NVIDIA's Exclusive "Golden Key" to AI Server Infrastructure

HONG KONG, Dec. 11, 2025 /PRNewswire/ -- I. Elite Certifications and Insurmountable Market Barriers * NVIDIA RVL Certification Yuans Technology is one of only five companies globally—and the only mainland China-based vendor—to hold NVIDIA's RVL (Recommended Vendor List) certification. This cre...

2025-12-11 13:13 1444

ODE TO NOBLE LABORERS

BEIJING, Dec. 10, 2025 /PRNewswire/ -- A report from China Daily: From master craftsmen and veterans mastering smart manufacturing to young pioneers in high-tech sectors, China's industrial workforce is transforming, capturing a sweeping journey of progress as the All-China Federation of Trade Un...

2025-12-11 11:24 1056

Noah Holdings Hosts Global Black Diamond Summit, Highlights Vision for AI-Driven Global Wealth Management Future

HONG KONG, Dec. 11, 2025 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive advisory services on global investment and asset allocation primarily for global Chinese high-net-w...

2025-12-11 11:21 2982

Tencent Cloud Risk Solutions: Leader in the Asia-Pacific Anti-fraud Market

SHENZHEN, China, Dec. 11, 2025 /PRNewswire/ -- Tencent Cloud Risk Solutions has been recognized as a Leader in The Forrester Wave™: Enterprise Fraud Management Solutions in theAsia Pacific, Q4 2025. Tencent Cloud received the highest scores in both service capabilities and strategy among all eval...

2025-12-11 10:00 1217

Updated Efficacy Data of Ivonescimab Combined with Chemotherapy as First-Line Treatment for TNBC Presented at ESMO IO 2025

HONG KONG, Dec. 10, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ivonescimab (a PD-1/VEGF bispecific antibody) combined with chemotherapy as a first-line treatment...

2025-12-11 09:53 1009

/DISREGARD RELEASE: Risen Energy Co., Ltd./

We are advised by Risen Energy Co., Ltd. that journalists and other readers should disregard the news release, 3GWh! Risen Energy Secures New Global Energy Storage Deal!, issued10-Dec-2025 over PR Newswire. The company told that the release contains some sensitive customer data which is not ready...

2025-12-11 02:39 1600

Creality Unveils Scan-to-CAD Workflow Through New QUICKSURFACE Partnership

SHENZHEN, China, Dec. 10, 2025 /PRNewswire/ -- Shenzhen Creality 3D Technology Co., Ltd. ("Creality"), a global provider of 3D printing and 3D scanning solutions, has recently officially announced a strategic partnership with KVS Ltd, developer of the QUICKSURFACE reverse-engineering platform. Th...

2025-12-11 02:00 1188

Lynk Pharmaceuticals and Formation Bio Enter Exclusive Development and Licensing Agreement for LNK01006

HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Bio today announced Formation Bio's acquisition of worldwide rights, excludingGreater China, to LNK01...

2025-12-10 22:05 1786

China Premiere of 'Avatar: Fire and Ash' Highlight of 7th HIIFF

HAIKOU, China, Dec. 10, 2025 /PRNewswire/ -- A report from Hainan International Media Center: On the evening of Dec. 9th, the 7th Hainan Island International Film Festival (HIIFF) concluded. This thrilling event was held just prior to the imminent start of island-wide special customs operations ...

2025-12-10 20:37 1040

NaaS Technology Inc. Regains Compliance with Nasdaq Minimum Market Value of Listed Securities Requirement

BEIJING, Dec. 10, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that on December 9, 2025, it received written notice from the Listing Qualifications Department (the "Staff") of Nasdaq...

2025-12-10 20:00 1216

Manycore Tech Unveils LuxReal: A 3D AI Content Creation Product Enhancing "Spatial Consistency" in AI Video

HANGZHOU, China, Dec. 10, 2025 /PRNewswire/ -- At the 2025 Cool+ Conference, Manycore Tech officially launched LuxReal, its innovative 3D AI content creation product designed to significantly improve the "spatial consistency" of AI-generated videos. LuxReal enables rapid generation of videos with...

2025-12-10 19:53 994

CNFINANCE ANNOUNCES THE RESULTS OF ITS EXTRAORDINARY GENERAL MEETING

GUANGZHOU, China, Dec. 10, 2025 /PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider inChina, today announced the results of its extraordinary general meeting of shareholders held at 22nd Floor, South Finance Building, ...

2025-12-10 19:15 2002

ORGE CO LTD Accelerates Global Expansion With Full-Scale Entry Into Chinese Market

SEOUL, South Korea, Dec. 10, 2025 /PRNewswire/ -- Korean organic food brand ORGE CO LTD is ramping up its global footprint as it moves forward with a full-scale entry into the Chinese market. The company recently held discussions with platform operators and local buyers at the Shanghai Food Tech ...

2025-12-10 18:43 956

Professor Youmin Xi honoured with University of Liverpool Fellowship

SUZHOU, China, Dec. 10, 2025 /PRNewswire/ -- Professor Youmin Xi, Executive President of Xi'an Jiaotong-Liverpool University (XJTLU), has received an Honorary Fellowship from theUniversity of Liverpool. The award recognises his success in leading XJTLU – an innovative partnership between theUniv...

2025-12-10 18:01 849

Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment

-Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a randomized, double-blind, placebo-controlled, multicenter Phase III clinical trial. HONG KONG, Dec. 10, 2025 ...

2025-12-10 17:15 925
123456 ... 1716

Week's Top Stories